Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Kava hepatotoxicity: pathogenetic aspects and prospective considerations.

Teschke R.

Liver Int. 2010 Oct;30(9):1270-9. doi: 10.1111/j.1478-3231.2010.02308.x. Review.

PMID:
20630022
2.

Kava hepatotoxicity--a clinical review.

Teschke R.

Ann Hepatol. 2010 Jul-Sep;9(3):251-65. Review.

PMID:
20720265
3.

Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.

Teschke R, Qiu SX, Xuan TD, Lebot V.

Phytother Res. 2011 Sep;25(9):1263-74. doi: 10.1002/ptr.3464. Epub 2011 Mar 28. Review.

PMID:
21442674
4.

Kava hepatotoxicity: a European view.

Teschke R, Schwarzenboeck A, Akinci A.

N Z Med J. 2008 Oct 3;121(1283):90-8. Review.

PMID:
18841189
5.

Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits.

Teschke R, Qiu SX, Lebot V.

Dig Liver Dis. 2011 Sep;43(9):676-81. doi: 10.1016/j.dld.2011.01.018. Epub 2011 Mar 4. Review.

PMID:
21377431
6.

Role of ethanol in kava hepatotoxicity.

Li XZ, Ramzan I.

Phytother Res. 2010 Apr;24(4):475-80. doi: 10.1002/ptr.3046. Review.

PMID:
19943335
7.

Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?

Teschke R, Wolff A.

Regul Toxicol Pharmacol. 2011 Feb;59(1):1-7. doi: 10.1016/j.yrtph.2010.09.006. Epub 2010 Sep 18. Review.

PMID:
20854865
8.

[Kava, kavapyrones and toxic liver injury].

Teschke R.

Z Gastroenterol. 2003 May;41(5):395-404. Review. German.

PMID:
12772052
9.

Kava kava: examining new reports of toxicity.

Clouatre DL.

Toxicol Lett. 2004 Apr 15;150(1):85-96. Review.

PMID:
15068826
10.

Constituents in kava extracts potentially involved in hepatotoxicity: a review.

Olsen LR, Grillo MP, Skonberg C.

Chem Res Toxicol. 2011 Jul 18;24(7):992-1002. doi: 10.1021/tx100412m. Epub 2011 May 3. Review.

PMID:
21506562
11.

Review article: herbal and dietary supplement hepatotoxicity.

Bunchorntavakul C, Reddy KR.

Aliment Pharmacol Ther. 2013 Jan;37(1):3-17. doi: 10.1111/apt.12109. Epub 2012 Nov 5. Review.

12.

Kava extracts: safety and risks including rare hepatotoxicity.

Teschke R, Gaus W, Loew D.

Phytomedicine. 2003;10(5):440-6. Review.

PMID:
12834011
13.

Kava Hepatotoxicity: Are we any closer to the truth?

Anke J, Ramzan I.

Planta Med. 2004 Mar;70(3):193-6. Review.

PMID:
15114493
14.

Clinical and causality assessment in herbal hepatotoxicity.

Teschke R, Schwarzenboeck A, Eickhoff A, Frenzel C, Wolff A, Schulze J.

Expert Opin Drug Saf. 2013 May;12(3):339-66. doi: 10.1517/14740338.2013.774371. Epub 2013 Mar 5. Review.

PMID:
23458441
15.

Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, Terranova D, Busardò FP, Marinelli E.

Int J Mol Sci. 2016 Apr 16;17(4):580. doi: 10.3390/ijms17040580. Review.

16.

Potential for interaction of kava and St. John's wort with drugs.

Singh YN.

J Ethnopharmacol. 2005 Aug 22;100(1-2):108-13. Review.

PMID:
16005588
17.

Kava-kava and anxiety: growing knowledge about the efficacy and safety.

Bilia AR, Gallon S, Vincieri FF.

Life Sci. 2002 Apr 19;70(22):2581-97. Review.

PMID:
12269386
18.

Herbal hepatotoxicity: suspected cases assessed for alternative causes.

Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C.

Eur J Gastroenterol Hepatol. 2013 Sep;25(9):1093-8. doi: 10.1097/MEG.0b013e3283603e89. Review.

PMID:
23510966
19.

Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).

Anke J, Ramzan I.

J Ethnopharmacol. 2004 Aug;93(2-3):153-60. Review.

PMID:
15234747
20.

Herbal hepatotoxicity: a tabular compilation of reported cases.

Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A.

Liver Int. 2012 Nov;32(10):1543-56. doi: 10.1111/j.1478-3231.2012.02864.x. Epub 2012 Aug 28. Review.

PMID:
22928722

Supplemental Content

Support Center